Altered Quinidine Disposition in a Patient with Chronic Active Hepatitis
Overview
Overview
Journal
Postgrad Med J
Publisher
Oxford University Press
Specialty
General Medicine
Date
1982 Feb 1
PMID
7100030
Citations
2
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Guide to drug dosage in hepatic disease.
Bass N, Williams R Clin Pharmacokinet. 1988; 15(6):396-420.
PMID: 3072141 DOI: 10.2165/00003088-198815060-00004.
Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.
Bauman J, Schoen M, Hoon T Clin Pharmacokinet. 1991; 20(2):151-66.
PMID: 2029806 DOI: 10.2165/00003088-199120020-00006.
References
1.
Chien Y, Lambert H, Karim A
. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins. J Pharm Sci. 1974; 63(12):1877-9.
DOI: 10.1002/jps.2600631210.
View
2.
Ueda C, Hirschfeld D, Scheinman M, Rowland M, Williamson B, Dzindzio B
. Disposition kinetics of quinidine. Clin Pharmacol Ther. 1976; 19(1):30-6.
DOI: 10.1002/cpt197619130.
View
3.
Affrime M, Reidenberg M
. The protein binding of some drugs in plasma from patients with alcoholic liver disease. Eur J Clin Pharmacol. 1975; 8(3-4):267-9.
DOI: 10.1007/BF00567126.
View
4.
Conrad K, Molk B, Chidsey C
. Pharmacokinetic studies of quinidine in patients with arrhythmias. Circulation. 1977; 55(1):1-7.
View
5.
Perez-Mateo M, Erill S
. Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency. Eur J Clin Pharmacol. 1977; 11(3):225-31.
DOI: 10.1007/BF00606415.
View